Skip to content

The Effect of Exercise on Myokine Production in Aging Persons

Does an Acute Exercise Bout Increases Soluble and Muscle Myokine Concentration in Healthy, Older Persons

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05571709
Acronym
EXI-AGE
Enrollment
20
Registered
2022-10-07
Start date
2022-09-15
Completion date
2023-12-31
Last updated
2023-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Exercise

Brief summary

The incidence of age-related diseases, such as cancer and cardiovascular diseases, rapidly rises. These days, age-related diseases cause the majority of all healthcare expenses. During ageing senescent cells secrete a range of harmful inflammatory signals, which leads to chronic inflammation (inflamm-aging) and accelerates aging throughout the rest of the body. Interestingly, people who regularly exercise show less signs of inflamm-aging compared to people with a sedentary lifestyle. Molecules secreted by skeletal muscles, called myokines, may play an important role. However, the underlying molecular mechanisms remain unknown. This pilot study aims to investigate if an acute bout of resistance training is an appropriate tool to induce an increase in the release of muscle derived myokines in aged persons.

Interventions

PROCEDUREPercutaneous muscle biopsy

Muscle biopsy of the vastus lateralis (m. quadriceps)

OTHERExercise training

Resistance training of the lower limbs

BEHAVIORALQuestionnaire

Physical activity questionnaire

PROCEDUREBlood sample

Venous blood sample

Sponsors

Hasselt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Aged individuals who perform exercise training are compared to aged individuals who remain sedentary.

Eligibility

Sex/Gender
ALL
Age
65 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy persons

Exclusion criteria

* Smoking * Infection \< 2 weeks ago * Received a vaccine \< 2 weeks ago * Allergy to Lidocain * Immune deficiency * Presence of a tumour or in treatment * Usage of anti-coagulant medication * Presence of following conditions: * Haemophilia * Auto-immune disease * Cardiovascular disease * Musculoskeletal diseases which refrains the patient from exercising

Design outcomes

Primary

MeasureTime frameDescription
Myokine gene expressionDay 2Quantitative PCR (polymerase chain reaction) of markers in muscle tissue
Myokine productionDay 2Immunohistochemistry staining (fluorescent) of multiple myokines (for example: IL-6, IL-15, IL-4, irisin..) and aging markers (p16,p21...) on muscle tissue
Immune parametersDay 2Flow cytometry panels of immune parameters in muscle tissue
Myokine protein levelsDay 2Western blotting of multiple myokines in muscle tissue
Cytokine concentrationDay 2Measurement of multiple cytokines in blood (for example: IL-6, IL-15, IL-4, irisin...) with ELISA's or multiplex assays

Secondary

MeasureTime frameDescription
Resting Heart RateDay 1Measured using an electronic sphygmomanometer
International Physical Activity Questionnaire (Short form)Day 1Measures the subjective level of activity of the last seven days. 7 questions regarding amount of time spent on certain activities.
Blood pressureDay 1The force of circulating blood on the walls of the arteries. Measured using an electronic sphygmomanometer

Countries

Belgium

Contacts

Primary ContactBert Op'T Eijnde, Prof. dr.
bert.opteijnde@uhasselt.be+3211292121
Backup ContactChiel Hex, MD.
chiel.hex@uhasselt.be

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026